Carbinoxamine (Maleate)

Carbinoxamine (Maleate) is antihistamine. Histamine mediates allergic and inflammatory reactions. It provides relief of symptoms of allergic reactions such as rash, hives, watery eyes, runny nose, itchy eyes and sneezing. Carbinoxamine (Maleate) is also used to treat motion sickness, for relief of anxiety or tension, or sleeplessness.

Brands
RHINOTUSSAL RHINOTUSSAL JUMSOL DAVEDIX DAVENOL FLUNEC-D TRIOCOF-SF TRIOCOF ASOVIL RONDEC-D RONDEC-TR
Adult Dose
Neonatal
Paedriatic
Characteristics
. It is of Synthetic origin and belongs to Ethanamine. . The Molecular Weight of Carbinoxamine (Maleate) is 406.87. It is weakly acidic drug.
Contraindications
Carbinoxamine (Maleate) is contraindicated in conditions like Hypertension,Coronary artery disease,Hypersensitivity to the drug,Breast feeding.
Effects
The symptomatic adverse reactions produced by Carbinoxamine (Maleate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Drowsiness, Nausea, Dry mouth.
Indications
Carbinoxamine (Maleate) is primarily indicated in conditions like Allergic rhinitis, Angioedema, Conjuctivitis, Urticaria.
Interactions
No data regarding the interactions of Carbinoxamine (Maleate) was found.
Interfrence
Risks
Drug should not be given to Pregnant Mothers, and Cardiac / Hypertensive Patients.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Liq Store Below 40°C. Do not Freeze. Protect from Sunlight and Moisture.
Warnings
Carbinoxamine should be used with caution in bone marrow depression. Patients should observe caution while driving or performing other task requiring alertness because it may cause drowsiness. It should be used with caution in patients with urinary retention, history of bronchial asthma, hyperthyroidism, cardiovascular or liver disease. It should be used with caution in person with acute or chronic respiratory impairment, especially in children. Do not give subcutaneously because irritation or lesion may occur.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.